President Trump announces deal to reduce cost of weight loss drugs

President Trump delivered remarks from the Oval Office Thursday, announcing a deal with pharmaceutical manufacturers Eli Lilly and Novo Nordisk to reduce the cost of certain popular weight loss drugs. The press conference ended abruptly after one of the participants experienced a medical episode.

The Brief

President Donald Trump announced a new agreement with Eli Lilly and Novo Nordisk to expand coverage and lower prices for popular obesity drugs Zepbound and Wegovy, part of the GLP-1 class of treatments.

The deal builds on Trump’s ongoing efforts to cut drug costs, following an executive order requiring drug companies to lower prices or face new federal payment limits.

While broader access and lower prices are expecte

See Full Page